| Jennifer Bacchus, PHARMD | |
|
201 Hospital Rd, Canton, GA 30114-2408 | |
| (770) 721-4916 | |
| Not Available |
| Full Name | Jennifer Bacchus |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 201 Hospital Rd, Canton, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033661269 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | RPH027346 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Bacchus, PHARMD 301 Golden Ct, Canton, GA 30114-6804 Ph: (404) 232-5838 | Jennifer Bacchus, PHARMD 201 Hospital Rd, Canton, GA 30114-2408 Ph: (770) 721-4916 |
News Archive
Researchers from the Singapore University of Technology and Design (SUTD) developed a method to perform direct ink writing (DIW) 3D printing of milk-based products at room temperature, while maintaining its temperature sensitive nutrients.
Denator AB announced today that the company has entered into a 2-year collaboration with the Maastricht MultiModal Molecular Imaging Institute (M4I) of Maastricht University, the Netherlands. As part of the collaboration, Denator will work closely with the M4I Division of Imaging Mass Spectrometry, headed by university professor Ron Heeren, to jointly develop and evaluate innovative sample stabilization approaches for clinical applications.
BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve the previously announced merger between the companies. On June 29, 2009, BioSante and Cell Genesys entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company.
Pfizer said today it will work with the U.S. Food and Drug Administration (FDA) to add expanded risk information in the Celebrex label following an FDA decision announced this morning to require boxed warnings of potential cardiovascular risk for all COX-2 pain relievers and all NSAIDs, including older non-specific drugs such as ibuprofen and naproxen.
› Verified 1 days ago
Dr. Samuel Wangunu Muraguri, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 512 Sapphire Valley Ln, Canton, GA 30114 Phone: 678-431-6272 | |
Dr. Tamara Riggleman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 6111 Hickory Flat Hwy, Canton, GA 30115 Phone: 770-479-7039 | |
Dr. Amal Azar, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2022 Cumming Hwy, Canton, GA 30115 Phone: 678-880-4312 | |
Dr. Jessica Pritchard, PHARMD, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3760 Sixes Rd, #110, Canton, GA 30114 Phone: 770-345-8378 | |
Cheryl Neely Bursmith, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 450 Northside Cherokee Blvd, Canton, GA 30115 Phone: 770-224-1200 | |
Dr. Christopher Peel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 120 Marietta Hwy, Canton, GA 30114 Phone: 678-880-0572 |